Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | MAOB | P27338 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.81 |
| ▸ | DHODH | Q02127 | 1/20 | 0.81 |
| ▸ | MGAM | O43451 | 1/20 | 0.72 |
| ▸ | CASP3 | P42574 | 1/20 | 0.70 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.70 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.70 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.69 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.69 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.60 |
| ▸ | TYR | P14679 | 2/20 | 0.60 |
| ▸ | PPARG | P37231 | 2/20 | 0.60 |
| ▸ | PPARA | Q07869 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xanthoangelol SCHEMBL5519362 | 1.00 | MEN1 (1.00) | MEN1LMNAMAPTMAOBKMT2A | |
| Xanthoangelol SCHEMBL5519356 | 1.00 | MEN1 (1.00) | MEN1LMNAMAPTMAOBKMT2A | |
| SCHEMBL5515022 | 0.99 | MEN1 (0.98) | MEN1LMNAMAPTMAOBKMT2A | |
| SCHEMBL14523853 | 0.99 | MEN1 (0.98) | MEN1LMNAMAPTMAOBKMT2A | |
| SCHEMBL5515052 | 0.92 | MAOB (0.84) | MEN1LMNAMAPTMAOBKMT2A | |
| SCHEMBL5515048 | 0.92 | MAOB (0.84) | MEN1LMNAMAPTMAOBKMT2A | |
| SCHEMBL5515045 | 0.92 | MAOB (0.84) | MEN1LMNAMAPTMAOBKMT2A | |
| SCHEMBL14523856 | 0.91 | MEN1 (0.84) | MEN1LMNAMAPTMAOBKMT2A | |
| SCHEMBL21716621 | 0.90 | MAOB (0.82) | MEN1LMNAMAPTMAOBKMT2A | |
| Isobavachalcone SCHEMBL600137 | 0.90 | PTPN1 (1.00) | MEN1LMNAMAPTMAOBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102422-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | UNIV EMORY (US) | 2026-04-16 | — | — | US | claimed |
| US-20250064877-A1 | COMPOSITION FOR INCREASING MUSCLE STRENGTH CONTAINING COMPLEX EXTRACT OF ANGELICA KEISKEI AND LEAVES OF MORUS ALBA L. | HAMSOA PHARMACEUTICAL CO., LTD. (KR) | 2025-02-27 | — | — | US | claimed |
| US-20240269210-A1 | METHOD FOR ENHANCING BIOLOGICAL ENERGY WITH EXTRACT | TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD. (TW) | 2024-08-15 | — | — | US | claimed |
| US-20240165143-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY | 2024-05-23 | — | — | US | claimed |
| WO-2024080512-A1 | COMPOSITION FOR INCREASING MUSCLE STRENGTH CONTAINING COMPLEX EXTRACT OF ANGELICA KEISKEI AND LEAVES OF MORUS ALBA L. | 주식회사 함소아제약 | 2024-04-18 | — | — | WO | claimed |
| EP-4040965-A2 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | Emory University (US) | 2022-08-17 | — | — | EP | claimed |
| CN-114867351-A | 4' -halo-containing nucleotide and nucleoside therapeutic compositions and uses related thereto | 埃默里大学 | 2022-08-05 | — | — | CN | claimed |
| WO-2021137913-A2 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2021-07-08 | — | — | WO | claimed |
| CN-112526023-A | Method for detecting content of 4-hydroxyderricin and xanthoangelol in angelica keiskei | 青岛天鼎信息科技有限公司 | 2021-03-19 | — | — | CN | claimed |
| WO-2020032154-A1 | ACETYLCHOLINESTERASE INHIBITOR | 株式会社東洋マテリアル | 2020-02-13 | — | — | WO | claimed |
| EP-2249641-A1 | NOVEL COMPOSITIONS CONTAINING XANTHOHUMOL-CYCLODEXTRIN COMPLEXES | Flaxan GmbH & Co. KG (US) | 2010-11-17 | — | — | EP | claimed |
| WO-2009126320-A1 | XANTHOHUMOL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES OR DISORDERS | BETAL, LLC (US) | 2009-10-15 | — | — | WO | claimed |
| WO-2009108379-A1 | NOVEL COMPOSITIONS CONTAINING XANTHOHUMOL-CYCLODEXTRIN COMPLEXES | FLAXAN GMBH & CO. KG (US) | 2009-09-03 | — | — | WO | claimed |
| US-20070092551-A1 | Therapeutic agent | TAKARA BIO INC. (JP) | 2007-04-26 | — | — | US | claimed |
| CN-1816328-A | Therapeutic agent | TAKARA BIO INC (JP) | 2006-08-09 | — | — | CN | claimed |
| EP-1666051-A2 | Remedies | Takara Bio, Inc. (JP) | 2006-06-07 | — | — | EP | claimed |
| EP-1623704-A1 | THERAPEUTIC AGENT | TAKARA BIO INC. (JP) | 2006-02-08 | — | — | EP | claimed |
| US-20040002423-A1 | Remedies | TAKARA BIO INC. (JP) | 2004-01-01 | — | — | US | claimed |
| CN-1422159-A | Therapeutic agents | TAKARA SHUZO CO (JP) | 2003-06-04 | — | — | CN | claimed |
| EP-1277473-A1 | REMEDIES | TAKARA BIO INC. (JP) | 2003-01-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102422-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | SARS1, ITK, SLC43A1 | MEN1 4748/4885LMNA 1958/4885MAPT 2568/4885 |
| US-20070092551-A1 | Therapeutic agent | FABP4, GPR119, IAPP | MEN1 2467/4885LMNA 2982/4885MAPT 2256/4885 |
| US-20240165143-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | PNP, PRPF4, HPRT1 | MEN1 4756/4885LMNA 3012/4885MAPT 2180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.